CONFIDENTIAL TREATMENT REQUESTED BY BLAKE INSOMNIA THERAPEUTICS. EXHIBIT A OF THIS DOCUMENT HAS BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND, WHERE APPLICABLE, HAVE BEEN MARKED WITH AN ASTERISK TO DENOTE WHERE OMISSIONS HAVE BEEN...Joint Venture Agreement • April 18th, 2017 • Blake Insomnia Therapeutics, Inc. • Services-personal services • Nevada
THIS JOINT VENTURE AGREEMENT ("Agreement"), made and entered into as of this 1 day of February, 2017 by and between Blake Insomnia Therapeutics Inc. , a Nevada corporation, with an address of 244 5th Avenue, Ste A-154, New York, NY 10001 (“Blake”) and Sajo Consulting LLC, a Nevada limited liability company, with an address of 6440 Sky Pointe Dr., Ste 140-149, Las Vegas, NV 89131 (“Sajo”), collectively referred as the “Parties”.
EXCLUSIVE CLINICAL STUDY AND DATA PURCHASE AGREEMENTExclusive Clinical Study and Data Purchase Agreement • April 18th, 2017 • Blake Insomnia Therapeutics, Inc. • Services-personal services • Delaware
THIS EXCLUSIVE CLINICAL STUDY AND DATA PURCHASE AGREEMENT (the “Agreement”) is made as of March 13, 2017 (the “Effective Date”) between BLAKE INSOMNIA THERAPEUTICS, INC., a Nevada corporation (“Blake”), and SAJO Consulting LLC, a Nevada corporation (“Sajo”).
